Here are the DEF 14A proxy statements from Neurogene, Inc. (NGNE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow NGNE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NGNE filings page.
Neurogene Inc. calls a virtual-only 2026 annual meeting on June 3, 2026 at 9:00 a.m. Eastern to elect two Class III directors, hold several advisory votes on executive pay and its frequency, and ratify Deloitte & Touche as auditor for 2026.
Stockholders of record on April 7, 2026, when 15,615,786 common shares were outstanding, may vote online, by phone, mail, or during the live webcast. The proxy details a classified six‑member board, majority and supermajority voting standards, and restrictions on stockholder‑called special meetings and written consents.
The filing also discloses 2025 executive pay, including salary, cash bonuses, stock options, and restricted/performance share units, plus change‑in‑control and termination protections for key executives such as CEO Rachel McMinn, President/CFO Christine Mikail, and CMO Julie Jordan.